SEC FORM 4
$2,525.00
Contineum Therapeutics, Inc. (CTNM)
Acquisition (code M) of 2,500 shares at $1.01 per share.
Reporting Person Stengone Carmine N. · Officer Title CEO and President · Transaction Code M
Traded Sep 8, 2026 · Disclosed Sep 8, 2026
Source: SEC Form 4 · 0001628280-26-060962 · filed 2026-09-08 · View filing →